《港股開市》恆指高開319點 科技股領漲 京東及藥明生物彈
美股道指昨日(23日)升215點或0.6%,納指創收市新高,港股在科技股帶動下高開。恆指高開319點或1.3%,報25,428點;國指高開122點或1.4%,報8,938點;恆生科技指數高開150點或2.5%,報6,171點。
京東(09618.HK)次季非公認會計準則淨利潤跌22%,股價高開5.2%報256.2元,京東物流(02618.HK)半年盈轉虧蝕153.6億元人民幣,股價高開2.4%報25.55元。
其他科技股方面,騰訊(00700.HK)回購23萬股涉資1億,股價高開3%報446.8元。阿里巴巴(09988.HK)高開3.1%報156.8元,小米(01810.HK)高開2.1%報24.85元,美團(03690.HK)高開2.6%報200.4元,百度(09888.HK)高開4.2%,阿里健康(00241.HK)高開3.4%。
醫藥股藥明生物(02269.HK)半年多賺1.5倍,股價高開8%報122元。美國食品及藥物管理局全面批准使用「復必泰」,復星醫藥(02196.HK)高開5%報56.95元。
其他股份方面,恆地(00012.HK)上半年基礎盈利按年增50.6%,股價高開0.7%報36.05元。匯控(00005.HK)低開0.1%報42.35元,港交所(00388.HK)高開1.1%報490元。
濠賭股銀娛(00027.HK)及金沙中國(01928.HK)各高開2.5%及1.8%。油價反彈逾5%,油股中石化(00386.HK)及中石油(00857.HK)各高開2.6%及3.3%,中海油(00883.HK)高開1.7%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.